Sequential treatment with bendamustine, followed by obinutuzumab (GA101) and venetoclax (ABT-199) in patients with chronic lymphocytic leukemia (CLL): results of the CLL2-BAG phase-II-trial of the German CLL study group (GCLLSG)-MedSci.cn

Sequential treatment with bendamustine, followed by obinutuzumab (GA101) and venetoclax (ABT-199) in patients with chronic lymphocytic leukemia (CLL): results of the CLL2-BAG phase-II-trial of the German CLL study group (GCLLSG)

Cramer, P; Tresckow, J; Bahlo, J; Robrecht, S; Al-Sawaf, O; Langerbeins, P; Engelke, A; Fink, AM; Fischer, K; Seiler, T; von Weikersthal, LF; Hebart, H; Kreuzer, KA; Rittgen, M; Kneba, M; Wendtner, C; Stilgenbauer, S; Eichhorst, B; Hallek, M

LEUKEMIA & LYMPHOMA, 2017; 58 ( ): 149

科室
- - 订阅+
  - 更多科室
工具
服务